AVERY W CATLIN Insider Trading $CLDX Celldex Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for AVERY W CATLIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of AVERY W CATLIN. AVERY W CATLIN is Sr. VP & CFO in Celldex Therapeutics, Inc. ($AVAN) and Director in Corbus Pharmaceuticals Holdings, Inc. ($CRBP) and Director in Provention Bio, Inc. ($PRVB).
AVERY W CATLIN in Celldex Therapeutics, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of AVERY W CATLIN: Sr. VP & CFO
Holdings: 83,586 shares
Latest Transaction: Sep 07 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of AVERY W CATLIN in Celldex Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CLDX, CRBP, PRVB
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 07 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 2.80 | 10,000 | 28,000 | 25,000 | |
| Sep 07 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 2.80 | 10,000 | 28,000 | 83,586 | 73.6 K to 83.6 K (+13.59 %) |
| Jun 09 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | A | 4.72 | 135,000 | 637,200 | 135,000 | |
| Jun 06 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 4.50 | 2,847 | 12,812 | 5,000 | |
| Jun 06 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 2.80 | 20,000 | 56,000 | 0 | |
| Jun 06 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 4.50 | 2,847 | 12,812 | 73,586 | 70.7 K to 73.6 K (+4.02 %) |
| Jun 06 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 2.80 | 20,000 | 56,000 | 70,739 | 50.7 K to 70.7 K (+39.42 %) |
| Mar 10 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 2.80 | 15,000 | 42,000 | 20,000 | |
| Mar 10 2016 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 2.80 | 15,000 | 42,000 | 50,739 | 35.7 K to 50.7 K (+41.97 %) |
| Nov 25 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 8.52 | 25,000 | 213,000 | 0 | |
| Nov 25 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Sell | S | 18.00 | 25,000 | 450,000 | 35,109 | 60.1 K to 35.1 K (-41.59 %) |
| Nov 25 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 8.52 | 25,000 | 213,000 | 60,109 | 35.1 K to 60.1 K (+71.21 %) |
| Sep 14 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 4.50 | 10,000 | 45,000 | 7,847 | |
| Sep 14 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 4.50 | 10,000 | 45,000 | 35,109 | 25.1 K to 35.1 K (+39.83 %) |
| Jun 16 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 8.52 | 25,000 | 213,000 | 0 | |
| Jun 16 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Sell | S | 24.59 | 25,000 | 614,753 | 24,609 | 49.6 K to 24.6 K (-50.39 %) |
| Jun 16 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 8.52 | 25,000 | 213,000 | 49,609 | 24.6 K to 49.6 K (+101.59 %) |
| Jun 11 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | A | 25.41 | 92,000 | 2,337,720 | 92,000 | |
| Jan 08 2009 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | A | 8.52 | 61,000 | 519,720 | 61,000 | |
| Jan 08 2009 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Grant | A | 0.00 | 5,868 | 0 | 7,759 | 1.9 K to 7.8 K (+310.31 %) |
| Jan 05 2009 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | L | 6.73 | 100 | 673 | 100 | 0 to 100 |
| Mar 11 2008 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | A | 8.16 | 183,333 | 1,495,997 | 183,333 | |
| Jul 02 2007 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | L | 0.71 | 500 | 353 | 21,500 | 21 K to 21.5 K (+2.38 %) |
| Jan 08 2007 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | A | 1.36 | 25,000 | 33,875 | 304,000 | |
| Aug 16 2006 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | P | 1.35 | 5,000 | 6,750 | 21,000 | 16 K to 21 K (+31.25 %) |
| Jul 03 2006 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | L | 1.37 | 500 | 685 | 16,000 | 15.5 K to 16 K (+3.23 %) |
| Jan 10 2006 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | A | 2.04 | 25,000 | 51,000 | 279,000 | |
| Nov 22 2005 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | C | 1.14 | 5,000 | 5,700 | 254,000 | |
| Nov 22 2005 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 1.14 | 5,000 | 5,700 | 15,500 | 10.5 K to 15.5 K (+47.62 %) |
| Jul 06 2005 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | L | 0.99 | 500 | 497 | 10,500 | 10 K to 10.5 K (+5.00 %) |
| Jan 05 2005 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | A | 2.08 | 12,000 | 24,900 | 259,000 | |
| Aug 04 2004 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | P | 1.83 | 3,500 | 6,388 | 10,000 | 6.5 K to 10 K (+53.85 %) |
| Jul 02 2004 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | L | 2.26 | 500 | 1,131 | 6,500 | 6 K to 6.5 K (+8.33 %) |
Page: 1